Insight

New study suggests significant overdiagnosis of prostate cancer in Europe – IARC

Photo taken from IARC/LinkedIn

Sep 9, 2024, 14:40

New study suggests significant overdiagnosis of prostate cancer in Europe – IARC

IARC – International Agency for Research on Cancer shared the following on LinkedIn:

“A new study, published today in The BMJ, suggests significant overdiagnosis of prostate cancer in Europe due to highly variable patterns of opportunistic testing with a blood test that measures the amount of prostate-specific antigen (PSA).”

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso

New study suggests significant overdiagnosis of prostate cancer in Europe - IARC

Source: IARC – International Agency for Research on Cancer/LinkedIn

Anssi Auvinen cancer Diego Serraino europe Freddie Bray IARC International Agency for Research on Cancer Luigino Dal Maso Mengmeng Li OncoDaily Oncology overdiagnosis prostate cancer PSA testing Rune Kvale Salvatore Vaccarella Valentina Lorenzoni

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

Special Coverage